Triple-negative inflammatory breast cancer is strongly associated with a poor prognosis compared with other subtypes of inflammatory breast cancer, which include hormonal receptor and HER2-defined subtypes. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.